Publications by authors named "Giovanni Ferrandi"
Article Synopsis
- Synthetic lethality is emerging as a key strategy for anticancer therapies, expanding beyond just PARP inhibitors for BRCA1/2-defective tumors.
- New molecular targets, particularly in DNA damage response, are quickly progressing to clinical trials, showcasing the growing interest in synthetic lethal approaches.
- The article highlights the latest developments in synthetic lethal targets, discusses their design and therapeutic strategies, and ends with an exploration of the challenges and opportunities for future research in this area.
